Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Intraocular Melanoma
			Melanoma (Skin)
2		Additional conditions recognized in this trial
			Eye Neoplasms
			Melanoma
3		More general conditions related to this trial
			Eye Diseases
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Germ Cell and Embryonal
			Neoplasms, Nerve Tissue
			Neuroectodermal Tumors
			Neuroendocrine Tumors
			Nevi and Melanomas
4		Interventions listed in this trial
			MART-1 antigen
			gp100 antigen
			incomplete Freund's adjuvant
			sargramostim
			tyrosinase peptide
			adjuvant therapy
5		Additional drug interventions recognized in this trial
			Freund's Adjuvant
6		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
7		Sponsors listed in this trial
			Eastern Cooperative Oncology Group
			National Cancer Institute (NCI)
			Southwest Oncology Group